Follow The Filings

BDX Becton Dickinson

Becton Dickinson earnings company data as of 5:13 PM ET 10/28

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 4.06 — —
Rev $5.11B — —

Insider trades

Open-market buys and sales by BDX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BDX insider trades
  • None no insider bought on the open market
  • $653K sold by 2 insiders outside a trading plan
  • $2.1M sold by 3 insiders under 10b5-1 plans
  1. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $15K 76 shares at $198.13 0.4% of stake
    Traded Oct 26 Filed Oct 27
  2. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $14K 76 shares at $183.70 0.4% of stake
    Traded Sep 28 Filed Sep 29
  3. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $31K 165 shares at $188.49 0.8% of stake
    Traded Aug 26 Filed Aug 27
  4. Thomas E Polen Jr. CEO
    Planned sale
    $768K 4,152 shares at $185.00 3.6% of stake
    Traded Aug 13 Filed Aug 14
  5. Roland Goette EVP and President, EMEA
    Sale
    $441K 2,438 shares at $180.84 14% of stake
    Traded Aug 11 Filed Aug 12
  6. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $12K 75 shares at $157.13 0.4% of stake
    Traded Jul 27 Filed Jul 28
  7. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $11K 75 shares at $152.80 0.4% of stake
    Traded Jun 26 Filed Jun 26
  8. Michael David Garrison EVP & Pres Med.Essntl&BioPharm
    Planned sale
    $160K 1,100 shares at $145.66 7.7% of stake
    Traded Jun 24 Filed Jun 25
  9. Michael David Garrison EVP & Pres Med.Essntl&BioPharm
    Planned sale
    $167K 1,100 shares at $151.48 7.2% of stake
    Traded Jun 10 Filed Jun 11
  10. Thomas E Polen Jr. CEO
    Planned sale
    $405K 2,764 shares at $146.35 2.4% of stake
    Traded Jun 1 Filed Jun 3
  11. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $11K 75 shares at $147.35 0.4% of stake
    Traded May 26 Filed May 27
  12. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $11K 74 shares at $151.94 0.3% of stake
    Traded Apr 27 Filed Apr 28
  13. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $12K 75 shares at $156.83 0.4% of stake
    Traded Mar 26 Filed Mar 27
  14. Michael Feld EVP, Chief Revenue Officer
    Planned sale
    $14K 75 shares at $181.84 0.4% of stake
    Traded Feb 26 Filed Feb 27
  15. Bertram L Scott Director
    Sale
    $174K 953 shares at $182.61 2.5% of stake
    Traded Feb 18 Filed Feb 18

Also filed in the last 12 months, not counted as buying or selling: 36 stock grants, 14 share withholdings for taxes, 3 sales back to the company, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.02,7.01,9.01
8-K 7.01
8-K 1.01,2.03,9.01
SCHEDULE 13G/A —
424B2
8-K 8.01,9.01
424B2
8-K 2.02,9.01
8-K/A 5.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.03,9.01
8-K 5.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.